Lymphopoiesis and matrix glycoprotein SC1/ECM2

Area of Science:

• Biochemistry
• Immunology
• Cell Biology

Background:

• The bone marrow microenvironment is critical for hematopoiesis.
• Identifying key molecular components of this microenvironment is essential for understanding immune cell development.
• Marrow stromal cells produce various extracellular matrix proteins that influence cell behavior.

Purpose of the Study:

• To investigate the role of matrix glycoprotein SC1/ECM2 (SC1/ECM2) in supporting B lymphocyte development.
• To determine if SC1/ECM2 can enhance B cell proliferation and cloning.
• To identify the functional domains of SC1/ECM2 responsible for augmenting lymphopoiesis.

Main Methods:

• Utilized cloning strategies to identify marrow stromal cell-derived molecules.
• Created a fusion protein of SC1/ECM2 and human immunoglobulin constant region.
• Assessed the binding affinity of the fusion protein to B lineage cells.
• Measured the effect of SC1/ECM2 on mitogen-dependent proliferation of mature B cells and cloning of pre-B cells.
• Expressed SC1/ECM2 as a transmembrane protein on fibroblasts to evaluate its impact on lymphopoiesis.

Main Results:

• SC1/ECM2, a calcium-binding secreted protein, was identified as a component of the bone marrow microenvironment.
• A SC1/ECM2 fusion protein demonstrated divalent cation-dependent binding to B lineage cells.
• Addition of the SC1/ECM2 fusion protein dose-dependently increased mature B cell proliferation and pre-B cell cloning.
• SC1/ECM2 also augmented lymphopoiesis when expressed as a transmembrane protein.

Conclusions:

• SC1/ECM2 plays a significant role in supporting B lymphocyte development and lymphopoiesis.
• The amino-terminal portion of SC1/ECM2 is sufficient for augmenting lymphocyte growth.
• Understanding SC1/ECM2's function advances the potential for engineering supportive microenvironments for lympho-hematopoiesis.